Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127137101 | 12713710 | 1 | I | 20160824 | 20160904 | 20160904 | PER | US-JNJFOC-20160900144 | JOHNSON AND JOHNSON | 0.00 | E | F | Y | 0.00000 | 20160904 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127137101 | 12713710 | 1 | PS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | U | U | UNKNOWN | 19835 | TABLET | |||||||
| 127137101 | 12713710 | 2 | SS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | U | U | UNKNOWN | 19835 | 1 | DF | TABLET | |||||
| 127137101 | 12713710 | 3 | C | ZYRTEC-D | CETIRIZINE HYDROCHLORIDEPSEUDOEPHEDRINE HYDROCHLORIDE | 1 | Oral | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127137101 | 12713710 | 2 | Hypersensitivity |
| 127137101 | 12713710 | 3 | Hypersensitivity |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127137101 | 12713710 | Drug administration error | |
| 127137101 | 12713710 | Drug effect incomplete |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |